Literature DB >> 10548117

Serial visual evoked potentials in 90 untreated patients with acute optic neuritis.

J L Frederiksen1, J Petrera.   

Abstract

To establish the value of visual evoked potentials (VEPs) for monitoring disease evolution, we undertook a population-based study of 90 untreated patients 12 to 57 years of age (median, 32 years) at the onset of optic neuritis (ON) and after 2, 4, 12, and 52 weeks. Optic neuritis was monosymptomatic (AMON) in 58 patients and part of the clinically definite multiple sclerosis (CDMS) in 32 patients. The VEP was abnormal in eyes with acute ON in 69 (77%) of 90 patients at onset and in 80 (89%) of 90 patients at one or more of the follow-up sessions. In eyes with acute ON, normalization of an initially abnormal VEP was observed during 1-year follow-up in 13 (19%) of 69 patients. At onset of ON, VEP was abnormal in 35% of the clinically unaffected eyes. By parametric analysis of variance, the latencies (P = 0.0058), the amplitudes (P = 0.0298), and the combined VEP scores (P = 0.0345) in the eyes with acute ON were significantly associated with the time after onset. The latencies were influenced by the presence of CDMS (P = 0.0033), whereas the amplitudes were influenced by visual acuity (P = 0.0000). When visual acuity was included in a multifactor model, the time after onset was, however, not significantly associated with the amplitude (P = 0.8826). The mean latency of the VEPs in eyes with acute ON was significantly shorter in AMON than in ON as part of CDMS. This study provides evidence that VEP abnormality is often transitory, and that VEP often normalizes during follow-up. The diagnostic yield is increased by repeating VEP in the spontaneous course of acute ON. Visual evoked potential is a sensitive tool for revealing subclinical lesions.

Entities:  

Mesh:

Year:  1999        PMID: 10548117     DOI: 10.1016/s0039-6257(99)00095-8

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  19 in total

1.  Normalisation of visual evoked potentials after optic neuritis.

Authors:  Rudy R Hidajat; David H Goode
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

2.  Visual evoked potentials findings in non-affected subjects from a large Brazilian pedigree of 11778 Leber's hereditary optic neuropathy.

Authors:  Paula Yuri Sacai; Solange Rios Salomão; Valerio Carelli; Josenilson Martins Pereira; Rubens Belfort; Alfredo Arrigo Sadun; Adriana Berezovsky
Journal:  Doc Ophthalmol       Date:  2010-07-31       Impact factor: 2.379

Review 3.  Neurophysiological markers.

Authors:  Letizia Leocani; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

4.  Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.

Authors:  R T Naismith; N T Tutlam; J Xu; J B Shepherd; E C Klawiter; S-K Song; A H Cross
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

5.  Independent patterns of damage to retinocortical pathways in multiple sclerosis without a previous episode of optic neuritis.

Authors:  Aldina Reis; Catarina Mateus; M Carmo Macário; José R Faria de Abreu; Miguel Castelo-Branco
Journal:  J Neurol       Date:  2011-03-31       Impact factor: 4.849

6.  Contrast sensitivity, first-order motion and Initial ocular following in demyelinating optic neuropathy.

Authors:  Janet C Rucker; Boris M Sheliga; Edmond J Fitzgibbon; Frederick A Miles; R John Leigh
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

7.  Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.

Authors:  Michal Laron; Han Cheng; Bin Zhang; Jade S Schiffman; Rosa A Tang; Laura J Frishman
Journal:  Mult Scler       Date:  2009-12-07       Impact factor: 6.312

8.  The role of the multifocal visual evoked potential (mfVEP) latency in understanding optic nerve and retinal diseases.

Authors:  Donald C Hood; John Y Chen; E Bo Yang; Chris Rodarte; Adam S Wenick; Tomas M Grippo; Jeffrey G Odel; Robert Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Functional-structural assessment of the optic pathways in patients with optic neuritis.

Authors:  Mathias Falck Schmidt; Gorm Pihl-Jensen; Jette Lautrup Frederiksen
Journal:  Doc Ophthalmol       Date:  2019-10-17       Impact factor: 2.379

10.  Low conversion rate to multiple sclerosis in idiopathic optic neuritis patients in Taiwan.

Authors:  Yen-Ching Lin; May-Yung Yen; Wen-Ming Hsu; Hui-Chen Lee; An-Guor Wang
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.